Eubiotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Probiotics is the fastest growing segment, Asia-Pacific is the largest regional market

The Global Eubiotics Market, valued at USD 7.94 Billion in 2024, is projected to grow at a CAGR of 7.91% to reach USD 12.54 Billion by 2030. Eubiotics - encompassing probiotics, prebiotics, organic acids, and essential oils - are used to promote a balanced gut microflora in animals, enhancing overall health and productivity. Market growth is primarily driven by rising demand for natural feed additives, heightened awareness of livestock health, and global regulatory restrictions on antibiotic growth promoters.

Key Market Drivers

The growth of the Global Eubiotics Market is significantly influenced by stringent regulations on antibiotic growth promoters

Global regulatory efforts to combat antimicrobial resistance are compelling livestock producers to adopt alternatives to antibiotic growth promoters, thereby accelerating demand for eubiotics. According to the European Medicines Agency’s thirteenth annual ESVAC report published in November 2023, sales of veterinary antibiotics in 25 European countries declined by 53% between 2011 and 2022, creating a substantial shift toward non-antibiotic feed additives. In parallel, rising consumer preference for antibiotic-free animal products strengthens market demand.

Growing awareness of antibiotic residues in meat and the public health threat of antimicrobial resistance has led consumers to favor proteins produced through natural feed solutions. The European Environment Agency reported in May 2024 that antimicrobial-resistant infections cause approximately 35,000 deaths annually in the European Economic Area, reinforcing consumer urgency. This industry momentum is further reflected in related sectors, such as dsm-firmenich’s Feed Enzymes Alliance, which accounted for about €300 million in annual net sales in 2024, demonstrating strong market activity in advanced feed solutions.

Key Market Challenges

A significant challenge impeding the growth of the Global Eubiotics Market is the combination of high production costs and complex regulatory frameworks

Advanced eubiotic formulations require substantial investment in production, resulting in higher product prices that can limit adoption, especially among small and medium-sized livestock operations. This cost barrier reduces competitiveness against traditional feed additives. Additionally, stringent regulatory standards significantly increase development expenses and time-to-market. Extensive safety and efficacy testing is required for approval, further elevating costs and slowing innovation. Eurostat reported that EU gross domestic expenditure on research and development reached €389 billion in 2023, illustrating the high financial burden associated with innovation in regulated sectors such as feed additives. These combined pressures limit new product entry and restrict the market’s ability to scale rapidly.

Key Market Trends

Advancements in Eubiotic Formulation and Delivery Technologies

Innovations in formulation are enabling more stable, targeted, and effective eubiotic products designed to withstand gastrointestinal conditions and deliver optimal benefits. These advancements improve nutrient absorption, gut health, and overall animal performance. In 2023, Novozymes partnered with Bactolife to commercialize Ablacto+, a biosolution aimed at improving piglet gut stability and reducing post-weaning diarrhea, highlighting the movement toward next-generation biological products.

Key Market Players Profiled:

Novozymes A/S
Cargill, Incorporated
DuPont de Nemours, Inc.
Koninklijke DSM N. V.
Lallemand Inc.
Novus International, Inc.
Kemin Industries, Inc.
Asahi Group Holdings, Ltd.

Report Scope:

In this report, the Global Eubiotics Market has been segmented into the following categories:

By Type:

Probiotics
Prebiotics
Organic Acids
Essential Oils

By Livestock:

Poultry
Swine
Ruminants
Aquatic Animals
Others

By Function:

Nutrition & Gut Health
Yield
Immunity & Production

By Form:

Dry
Liquid

By Region:

North America
Europe
Asia-Pacific
South America
Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Eubiotics Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Eubiotics Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Probiotics, Prebiotics, Organic Acids, Essential Oils)
5.2.2. By Livestock (Poultry, Swine, Ruminants, Aquatic Animals, Others)
5.2.3. By Function (Nutrition & Gut Health, Yield, Immunity & Production)
5.2.4. By Form (Dry, Liquid)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map

6. North America Eubiotics Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Livestock
6.2.3. By Function
6.2.4. By Form
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Eubiotics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Livestock
6.3.1.2.3. By Function
6.3.1.2.4. By Form
6.3.2. Canada Eubiotics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Livestock
6.3.2.2.3. By Function
6.3.2.2.4. By Form
6.3.3. Mexico Eubiotics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Livestock
6.3.3.2.3. By Function
6.3.3.2.4. By Form

7. Europe Eubiotics Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Livestock
7.2.3. By Function
7.2.4. By Form
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Eubiotics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Livestock
7.3.1.2.3. By Function
7.3.1.2.4. By Form
7.3.2. France Eubiotics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Livestock
7.3.2.2.3. By Function
7.3.2.2.4. By Form
7.3.3. United Kingdom Eubiotics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Livestock
7.3.3.2.3. By Function
7.3.3.2.4. By Form
7.3.4. Italy Eubiotics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Livestock
7.3.4.2.3. By Function
7.3.4.2.4. By Form
7.3.5. Spain Eubiotics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Livestock
7.3.5.2.3. By Function
7.3.5.2.4. By Form

8. Asia-Pacific Eubiotics Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Livestock
8.2.3. By Function
8.2.4. By Form
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Eubiotics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Livestock
8.3.1.2.3. By Function
8.3.1.2.4. By Form
8.3.2. India Eubiotics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Livestock
8.3.2.2.3. By Function
8.3.2.2.4. By Form
8.3.3. Japan Eubiotics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Livestock
8.3.3.2.3. By Function
8.3.3.2.4. By Form
8.3.4. South Korea Eubiotics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Livestock
8.3.4.2.3. By Function
8.3.4.2.4. By Form
8.3.5. Australia Eubiotics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Livestock
8.3.5.2.3. By Function
8.3.5.2.4. By Form

9. Middle East & Africa Eubiotics Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Livestock
9.2.3. By Function
9.2.4. By Form
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Eubiotics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Livestock
9.3.1.2.3. By Function
9.3.1.2.4. By Form
9.3.2. UAE Eubiotics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Livestock
9.3.2.2.3. By Function
9.3.2.2.4. By Form
9.3.3. South Africa Eubiotics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Livestock
9.3.3.2.3. By Function
9.3.3.2.4. By Form

10. South America Eubiotics Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Livestock
10.2.3. By Function
10.2.4. By Form
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Eubiotics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Livestock
10.3.1.2.3. By Function
10.3.1.2.4. By Form
10.3.2. Colombia Eubiotics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Livestock
10.3.2.2.3. By Function
10.3.2.2.4. By Form
10.3.3. Argentina Eubiotics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Livestock
10.3.3.2.3. By Function
10.3.3.2.4. By Form

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Eubiotics Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Novozymes A/S
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Cargill, Incorporated
15.3. DuPont de Nemours, Inc.
15.4. Koninklijke DSM N. V.
15.5. Lallemand Inc.
15.6. Novus International, Inc.
15.7. Kemin Industries, Inc.
15.8. Asahi Group Holdings, Ltd.

16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Eubiotics market report include:

Novozymes A/S
Cargill, Incorporated
DuPont de Nemours, Inc.
Koninklijke DSM N. V.
Lallemand Inc.
Novus International, Inc.
Kemin Industries, Inc.
Asahi Group Holdings, Ltd.

Table Information

Report Attribute	Details
No. of Pages	185
Published	November 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.94 Billion
Forecasted Market Value ( USD ) by 2030	$ 12.54 Billion
Compound Annual Growth Rate	7.9%
Regions Covered	Global
No. of Companies Mentioned	9

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3969EUR$4,500USD£3,478GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4851EUR$5,500USD£4,250GBP